FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361823328> ?p ?o ?g. }

• W4361823328 abstract "<div>Abstract<p>Excess stroma and cancer-associated fibroblasts (CAF) enhance cancer progression and facilitate immune evasion. Insights into the mechanisms by which the stroma manipulates the immune microenvironment could help improve cancer treatment. Here, we aimed to elucidate potential approaches for stromal reprogramming and improved cancer immunotherapy. Platelet-derived growth factor C (PDGFC) and D expression were significantly associated with a poor prognosis in patients with gastric cancer, and PDGF receptor beta (PDGFRβ) was predominantly expressed in diffuse-type gastric cancer stroma. CAFs stimulated with PDGFs exhibited markedly increased expression of CXCL1, CXCL3, CXCL5, and CXCL8, which are involved in polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) recruitment. Fibrotic gastric cancer xenograft tumors exhibited increased PMN-MDSC accumulation and decreased lymphocyte infiltration, as well as resistance to anti–PD-1. Single-cell RNA sequencing and spatial transcriptomics revealed that PDGFRα/β blockade reversed the immunosuppressive microenvironment through stromal modification. Finally, combining PDGFRα/β blockade and anti–PD-1 treatment synergistically suppressed the growth of fibrotic tumors. These findings highlight the impact of stromal reprogramming on immune reactivation and the potential for combined immunotherapy for patients with fibrotic cancer.</p>Significance:<p>Stromal targeting with PDGFRα/β dual blockade reverses the immunosuppressive microenvironment and enhances the efficacy of immune checkpoint inhibitors in fibrotic cancer.</p><p><i><a href=https://aacrjournals.org/cancerres/article/doi/10.1158/0008-5472.CAN-22-3677 target=_blank>See related commentary by Tauriello, p. 655</a></i></p></div>" @default.
• W4361823328 created "2023-04-05" @default.
• W4361823328 creator A5001667760 @default.
• W4361823328 creator A5003742732 @default.
• W4361823328 creator A5004189669 @default.
• W4361823328 creator A5004940704 @default.
• W4361823328 creator A5008395718 @default.
• W4361823328 creator A5012135733 @default.
• W4361823328 creator A5015480910 @default.
• W4361823328 creator A5017277974 @default.
• W4361823328 creator A5018077403 @default.
• W4361823328 creator A5018669075 @default.
• W4361823328 creator A5021815000 @default.
• W4361823328 creator A5022270161 @default.
• W4361823328 creator A5028668436 @default.
• W4361823328 creator A5034461650 @default.
• W4361823328 creator A5039137137 @default.
• W4361823328 creator A5046865992 @default.
• W4361823328 creator A5051812511 @default.
• W4361823328 creator A5053802476 @default.
• W4361823328 creator A5062543717 @default.
• W4361823328 creator A5070955736 @default.
• W4361823328 creator A5072733384 @default.
• W4361823328 creator A5075398219 @default.
• W4361823328 creator A5075511892 @default.
• W4361823328 creator A5076385471 @default.
• W4361823328 creator A5080272176 @default.
• W4361823328 creator A5081028959 @default.
• W4361823328 date "2023-03-31" @default.
• W4361823328 modified "2023-10-16" @default.
• W4361823328 title "Data from Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors" @default.
• W4361823328 doi "https://doi.org/10.1158/0008-5472.c.6514332.v1" @default.
• W4361823328 hasPublicationYear "2023" @default.
• W4361823328 type Work @default.
• W4361823328 citedByCount "0" @default.
• W4361823328 crossrefType "posted-content" @default.
• W4361823328 hasAuthorship W4361823328A5001667760 @default.
• W4361823328 hasAuthorship W4361823328A5003742732 @default.
• W4361823328 hasAuthorship W4361823328A5004189669 @default.
• W4361823328 hasAuthorship W4361823328A5004940704 @default.
• W4361823328 hasAuthorship W4361823328A5008395718 @default.
• W4361823328 hasAuthorship W4361823328A5012135733 @default.
• W4361823328 hasAuthorship W4361823328A5015480910 @default.
• W4361823328 hasAuthorship W4361823328A5017277974 @default.
• W4361823328 hasAuthorship W4361823328A5018077403 @default.
• W4361823328 hasAuthorship W4361823328A5018669075 @default.
• W4361823328 hasAuthorship W4361823328A5021815000 @default.
• W4361823328 hasAuthorship W4361823328A5022270161 @default.
• W4361823328 hasAuthorship W4361823328A5028668436 @default.
• W4361823328 hasAuthorship W4361823328A5034461650 @default.
• W4361823328 hasAuthorship W4361823328A5039137137 @default.
• W4361823328 hasAuthorship W4361823328A5046865992 @default.
• W4361823328 hasAuthorship W4361823328A5051812511 @default.
• W4361823328 hasAuthorship W4361823328A5053802476 @default.
• W4361823328 hasAuthorship W4361823328A5062543717 @default.
• W4361823328 hasAuthorship W4361823328A5070955736 @default.
• W4361823328 hasAuthorship W4361823328A5072733384 @default.
• W4361823328 hasAuthorship W4361823328A5075398219 @default.
• W4361823328 hasAuthorship W4361823328A5075511892 @default.
• W4361823328 hasAuthorship W4361823328A5076385471 @default.
• W4361823328 hasAuthorship W4361823328A5080272176 @default.
• W4361823328 hasAuthorship W4361823328A5081028959 @default.
• W4361823328 hasConcept C121608353 @default.
• W4361823328 hasConcept C126322002 @default.
• W4361823328 hasConcept C13373296 @default.
• W4361823328 hasConcept C1491633281 @default.
• W4361823328 hasConcept C16930146 @default.
• W4361823328 hasConcept C170493617 @default.
• W4361823328 hasConcept C203014093 @default.
• W4361823328 hasConcept C204232928 @default.
• W4361823328 hasConcept C2776107976 @default.
• W4361823328 hasConcept C2777701055 @default.
• W4361823328 hasConcept C2778468042 @default.
• W4361823328 hasConcept C2780674031 @default.
• W4361823328 hasConcept C2780851360 @default.
• W4361823328 hasConcept C502942594 @default.
• W4361823328 hasConcept C52124034 @default.
• W4361823328 hasConcept C54355233 @default.
• W4361823328 hasConcept C71924100 @default.
• W4361823328 hasConcept C77255625 @default.
• W4361823328 hasConcept C86803240 @default.
• W4361823328 hasConcept C8891405 @default.
• W4361823328 hasConcept C96525457 @default.
• W4361823328 hasConceptScore W4361823328C121608353 @default.
• W4361823328 hasConceptScore W4361823328C126322002 @default.
• W4361823328 hasConceptScore W4361823328C13373296 @default.
• W4361823328 hasConceptScore W4361823328C1491633281 @default.
• W4361823328 hasConceptScore W4361823328C16930146 @default.
• W4361823328 hasConceptScore W4361823328C170493617 @default.
• W4361823328 hasConceptScore W4361823328C203014093 @default.
• W4361823328 hasConceptScore W4361823328C204232928 @default.
• W4361823328 hasConceptScore W4361823328C2776107976 @default.
• W4361823328 hasConceptScore W4361823328C2777701055 @default.
• W4361823328 hasConceptScore W4361823328C2778468042 @default.
• W4361823328 hasConceptScore W4361823328C2780674031 @default.
• W4361823328 hasConceptScore W4361823328C2780851360 @default.
• W4361823328 hasConceptScore W4361823328C502942594 @default.
• W4361823328 hasConceptScore W4361823328C52124034 @default.
• W4361823328 hasConceptScore W4361823328C54355233 @default.
• W4361823328 hasConceptScore W4361823328C71924100 @default.

• next